SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
210 hedge funds and large institutions have $751M invested in Sorrento Therapeutics, Inc. in 2021 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 70 increasing their positions, 54 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
210
Holders Change
-19
Holders Change %
-8.3%
% of All Funds
3.67%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.07%
New
30
Increased
70
Reduced
54
Closed
48
Calls
$96.7M
Puts
$46.9M
Net Calls
+$49.8M
Net Calls Change
+$13.3M
Top Buyers
| 1 |
D.E. Shaw & Co
New York
|
+$13.7M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.3M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.58M |
| 4 |
State Street
Boston,
Massachusetts
|
+$4.32M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$4.13M |
Top Sellers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$21.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$4.88M |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
-$3.9M |
| 4 |
MC
Mayo Clinic
Rochester,
Minnesota
|
-$3.29M |
| 5 |
BlackRock
New York
|
-$2.82M |
